FDA Puts Squeeze On SnugZ; Promo Product/OTC Drug Manufacturer Warned For CGMP Violations
Known for its customizable lanyards and eyewear retainers, SnugZ USA, Inc. also manufactures sunscreens and other personal-care items for corporate branding purposes. The FDA inspected the firm’s West Jordan, Utah facility in late 2018, finding significant violations of current good manufacturing practices, according to a warning letter posted to the agency’s website 9 July.
You may also be interested in...
FDA also imposes import alert on lip balms, hand sanitizers and sunscreens made by Ningbo HuiZe Commodity in Zhejiang, China. Alert subjects products to detention without physical examination at US international ports of entry.
Firms marketed products with label and other claims rendering them drugs but containing ingredients and label indications not part of OTC external analgesic TFM, recent warning letters say. Each firm also advised about GMP problems based on findings from Office of Regulatory Affairs' inspections and asked to hire regulatory consultants and provide detailed CAPAs.
As European industry’s concerns grow about “politicization” of regulatory programs, the United States-Mexico-Canada Agreement’s cosmetics annex directs regulatory authorities pursuing new rules to give due consideration to scientific and technical guidance documents developed through international collaboration.